Library Subscription: Guest
Critical Reviews™ in Oncogenesis

Published 4 issues per year

ISSN Print: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

NK Cells in the Tumor Microenvironment

Volume 19, Issue 1-2, 2014, pp. 91-105
DOI: 10.1615/CritRevOncog.2014011142
Get accessGet access

ABSTRACT

The presence of natural killer (NK) cells in the tumor microenvironment correlates with outcome in a variety of cancers. However, the role of intratumoral NK cells is unclear. Preclinical studies have shown that, while NK cells efficiently kill circulating tumor cells of almost any origin, they seem to have very little effect against the same type of tumor cells when these have extravasated. The ability to kill extravasated tumor cells is, however, is dependent of the level of activation of the NK cells, as more recent published and unpublished studies, discussed below, have demonstrated that interleukin-2−activated NK cells are able to attack well-established solid tumors.

CITED BY
  1. Oliveros-Bastidas Alberto, Calcagno-Pissarelli María Pía, Naya Marlene, Ávila-Núñez Jorge Luis, Alonso-Amelot Miguel E., Human gastric cancer, Helicobacter pylori and bracken carcinogens: A connecting hypothesis, Medical Hypotheses, 88, 2016. Crossref

  2. Goding Stephen R., Yu Shaohong, Bailey Lisa M., Lotze Michael T., Basse Per H., Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells, Clinical Immunology, 177, 2017. Crossref

  3. Cariani Elisabetta, Pilli Massimo, Barili Valeria, Porro Emanuela, Biasini Elisabetta, Olivani Andrea, Dalla Valle Raffaele, Trenti Tommaso, Ferrari Carlo, Missale Gabriele, Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments, OncoImmunology, 5, 8, 2016. Crossref

  4. Pommier Arnaud, Fearon Douglas T., Disruption of Anti-tumor T Cell Responses by Cancer-Associated Fibroblasts, in Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy, 9, 2016. Crossref

  5. Mahasa Khaphetsi Joseph, Ouifki Rachid, Eladdadi Amina, Pillis Lisette de, Mathematical model of tumor–immune surveillance, Journal of Theoretical Biology, 404, 2016. Crossref

  6. Muenst S., Läubli H., Soysal S. D., Zippelius A., Tzankov A., Hoeller S., The immune system and cancer evasion strategies: therapeutic concepts, Journal of Internal Medicine, 279, 6, 2016. Crossref

  7. Veluchamy John P., Lopez-Lastra Silvia, Spanholtz Jan, Bohme Fenna, Kok Nina, Heideman Daniëlle A. M., Verheul Henk M. W., Di Santo James P., de Gruijl Tanja D., van der Vliet Hans J., In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal Cancer, Frontiers in Immunology, 8, 2017. Crossref

  8. Sadozai Hassan, Gruber Thomas, Hunger Robert Emil, Schenk Mirjam, Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma, Frontiers in Immunology, 8, 2017. Crossref

  9. Croxatto D., Martini S., Chiossone L., Scordamaglia F., Simonassi C. F., Moretta L., Mingari M. C., Vacca P., IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid, OncoImmunology, 6, 4, 2017. Crossref

  10. Tomar Munendra Singh, Kumar Sanjay, Kumar Sanjay, Gautam Pramod Kumar, Singh Rishi Kant, Verma Praveen Kumar, Singh Surya Pratap, Acharya Arbind, NK Cell Effector Functions Regulation by Modulating nTreg Cell Population During Progressive Growth of Dalton’s Lymphoma in Mice, Immunological Investigations, 47, 1, 2018. Crossref

  11. Kaur Kawaljit, Cook Jessica, Park So-Hyun, Topchyan Paytsar, Kozlowska Anna, Ohanian Nick, Fang Changge, Nishimura Ichiro, Jewett Anahid, Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients, Frontiers in Immunology, 8, 2017. Crossref

  12. Semeraro Michaela, Pasqualini Claudia, Chaput Nathalie, Immune Biomarkers in Paediatric Malignancies, in Immunotherapy for Pediatric Malignancies, 2018. Crossref

  13. Muntasell Aura, Cabo Mariona, Servitja Sonia, Tusquets Ignasi, Martínez-García María, Rovira Ana, Rojo Federico, Albanell Joan, López-Botet Miguel, Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy, Frontiers in Immunology, 8, 2017. Crossref

  14. Beksac Alp Tuna, Paulucci David J., Blum Kyle A., Yadav Shalini Singh, Sfakianos John P., Badani Ketan K., Heterogeneity in renal cell carcinoma, Urologic Oncology: Seminars and Original Investigations, 35, 8, 2017. Crossref

  15. Xu Chen, Liu Dongning, Chen Zhixin, Zhuo Fan, Sun Huankui, Hu Jiaping, Li Taiyuan, Umbilical Cord Blood–Derived Natural Killer Cells Combined with Bevacizumab for Colorectal Cancer Treatment, Human Gene Therapy, 30, 4, 2019. Crossref

  16. Valdes-Mora Fatima, Handler Kristina, Law Andrew M. K., Salomon Robert, Oakes Samantha R., Ormandy Christopher J., Gallego-Ortega David, Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology, Frontiers in Immunology, 9, 2018. Crossref

  17. Lanuza Pilar M., Vigueras Alan, Olivan Sara, Prats Anne C., Costas Santiago, Llamazares Guillermo, Sanchez-Martinez Diego, Ayuso José María, Fernandez Luis, Ochoa Ignacio, Pardo Julián, Activated human primary NK cells efficiently kill colorectal cancer cells in 3D spheroid cultures irrespectively of the level of PD-L1 expression, OncoImmunology, 7, 4, 2018. Crossref

  18. Suen Wade Chun-Wai, Lee Wayne Yuk-Wai, Leung Kam-Tong, Pan Xiao-Hua, Li Gang, Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials, Cancer Investigation, 36, 8, 2018. Crossref

  19. Mishra Hemant K., Pore Nabendu, Michelotti Emil F., Walcheck Bruce, Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells, Cancer Immunology, Immunotherapy, 67, 9, 2018. Crossref

  20. Kim Juyoung, Kim Ji Sung, Lee Hong Kyung, Kim Hyung Sook, Park Eun Jae, Choi Jeong Eun, Choi Yeo Jin, Shin Bo Ram, Kim Eun Young, Hong Jin Tae, Kim Youngsoo, Han Sang-Bae, CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells, International Immunopharmacology, 63, 2018. Crossref

  21. Shen Minhong, Kang Yibin, Complex interplay between tumor microenvironment and cancer therapy, Frontiers of Medicine, 12, 4, 2018. Crossref

  22. Calmeiro João, Carrascal Mylene, Gomes Célia, Falcão Amílcar, Cruz Maria Teresa, Neves Bruno Miguel, Highlighting the Role of DC-NK Cell Interplay in Immunobiology and Immunotherapy, in Dendritic Cells, 2018. Crossref

  23. Porcellato Ilaria, Silvestri Serenella, Menchetti Laura, Recupero Francesca, Mechelli Luca, Sforna Monica, Iussich Selina, Bongiovanni Laura, Lepri Elvio, Brachelente Chiara, Tumour‐infiltrating lymphocytes in canine melanocytic tumours: An investigation on the prognostic role of CD3 + and CD20 + lymphocytic populations , Veterinary and Comparative Oncology, 18, 3, 2020. Crossref

  24. Burger Michael C., Zhang Congcong, Harter Patrick N., Romanski Annette, Strassheimer Florian, Senft Christian, Tonn Torsten, Steinbach Joachim P., Wels Winfried S., CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy, Frontiers in Immunology, 10, 2019. Crossref

  25. Fong Alexis, Durkin Amanda, Lee Hoyun, The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy, International Journal of Molecular Sciences, 20, 3, 2019. Crossref

  26. Shaul Merav E., Fridlender Zvi G., Tumour-associated neutrophils in patients with cancer, Nature Reviews Clinical Oncology, 16, 10, 2019. Crossref

  27. Pal Anasua, Zimmer Philipp, Schmidt Martina E., Hummel Manuela, Ulrich Cornelia M., Wiskemann Joachim, Steindorf Karen, No Evidence for Effect of Exercise on Transcriptome of NK Cells in Breast Cancer Patients Undergoing Adjuvant Therapy: Results From a Pilot Study, Frontiers in Physiology, 10, 2019. Crossref

  28. Wang Jingnan, Li Zhuoman, Gao Aiqin, Wen Qing, Sun Yuping, The prognostic landscape of tumor-infiltrating immune cells in cervical cancer, Biomedicine & Pharmacotherapy, 120, 2019. Crossref

  29. Ott Martina, Avendaño-Guzmán Erika, Ullrich Evelyn, Dreyer Carolin, Strauss Judith, Harden Markus, Schön Margarete, Schön Michael P., Bernhardt Günter, Stadelmann Christine, Wegner Christiane, Brück Wolfgang, Nessler Stefan, Laquinimod, a prototypic quinoline-3-carboxamide and aryl hydrocarbon receptor agonist, utilizes a CD155-mediated natural killer/dendritic cell interaction to suppress CNS autoimmunity, Journal of Neuroinflammation, 16, 1, 2019. Crossref

  30. Riera-Domingo Carla, Audigé Annette, Granja Sara, Cheng Wan-Chen, Ho Ping-Chih, Baltazar Fátima, Stockmann Christian, Mazzone Massimiliano, Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy, Physiological Reviews, 100, 1, 2020. Crossref

  31. Vujanovic Lazar, Chuckran Christopher, Lin Yan, Ding Fei, Sander Cindy A., Santos Patricia M., Lohr Joel, Mashadi-Hossein Afshin, Warren Sarah, White Andy, Huang Alan, Kirkwood John M., Butterfield Lisa H., CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α, Frontiers in Immunology, 10, 2019. Crossref

  32. Mukherjee Neelam, Ji Niannian, Hurez Vincent, Curiel Tyler J., Montgomery Maureen O., Braun Andrew J., Nicolas Marlo, Aguilera Marcela, Kaushik Dharam, Liu Qianqian, Ruan Jianhua, Kendrick Kerri A., Svatek Robert S., Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer, Oncotarget, 9, 92, 2018. Crossref

  33. Meza Guzman Lizeth G., Keating Narelle, Nicholson Sandra E., Natural Killer Cells: Tumor Surveillance and Signaling, Cancers, 12, 4, 2020. Crossref

  34. Xu Bin, Chen Lujun, Li Jing, Zheng Xiao, Shi Liangrong, Wu Changping, Jiang Jingting, Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients, Oncotarget, 7, 46, 2016. Crossref

  35. Tang Min, Gao Shenglin, Zhang Lei, Liu Bianjiang, Li Jie, Wang Zengjun, Zhang Wei, Docetaxel suppresses immunotherapy efficacy of natural killer cells toward castration‐resistant prostate cancer cells via altering androgen receptor‐lectin‐like transcript 1 signals, The Prostate, 80, 10, 2020. Crossref

  36. Neo Shi Yong, Yang Ying, Record Julien, Ma Ran, Chen Xinsong, Chen Ziqing, Tobin Nicholas P., Blake Emily, Seitz Christina, Thomas Ron, Wagner Arnika Kathleen, Andersson John, de Boniface Jana, Bergh Jonas, Murray Shannon, Alici Evren, Childs Richard, Johansson Martin, Westerberg Lisa S., Haglund Felix, Hartman Johan, Lundqvist Andreas, CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment, Journal of Clinical Investigation, 130, 3, 2020. Crossref

  37. Dufresne Suzanne, Guéritat Jordan, Chiavassa Sophie, Noblet Caroline, Assi Mohamad, Rioux‐Leclercq Nathalie, Rannou‐Bekono Françoise, Lefeuvre‐Orfila Luz, Paris François, Rébillard Amélie, Exercise training improves radiotherapy efficiency in a murine model of prostate cancer, The FASEB Journal, 34, 4, 2020. Crossref

  38. Salem Mohamed L., El-Naggar Sabry A., Mobasher Maysa A., Elgharabawy Rehab M., The Toll-Like Receptor 3 Agonist Polyriboinosinic Polyribocytidylic Acid Increases the Numbers of NK Cells with Distinct Phenotype in the Liver of B6 Mice, Journal of Immunology Research, 2020, 2020. Crossref

  39. Hernandez Carlos, Arasanz Hugo, Chocarro Luisa, Bocanegra Ana, Zuazo Miren, Fernandez-Hinojal Gonzalo, Blanco Ester, Vera Ruth, Escors David, Kochan Grazyna, Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies, International Journal of Molecular Sciences, 21, 7, 2020. Crossref

  40. Galon Jérôme, Bruni Daniela, Tumor Immunology and Tumor Evolution: Intertwined Histories, Immunity, 52, 1, 2020. Crossref

  41. Calmeiro João, Carrascal Mylène A., Tavares Adriana Ramos, Ferreira Daniel Alexandre, Gomes Célia, Falcão Amílcar, Cruz Maria Teresa, Neves Bruno Miguel, Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells, Pharmaceutics, 12, 2, 2020. Crossref

  42. Hadjidj Zeyneb, Messali Rabia, Aribi Mourad, Lack of cell movement impairs survival of peripheral blood IL-2-stimulated natural killer cells originating from solid cancer and promotes red blood cells to induce their switch toward a regulatory phenotype, Immunology Letters, 221, 2020. Crossref

  43. Georgescu Simona Roxana, Tampa Mircea, Mitran Cristina Iulia, Mitran Madalina Irina, Caruntu Constantin, Caruntu Ana, Lupu Mihai, Matei Clara, Constantin Carolina, Neagu Monica, Tumour Microenvironment in Skin Carcinogenesis, in Tumor Microenvironments in Organs, 1226, 2020. Crossref

  44. Valdés-Ferrada Javier, Muñoz-Durango Natalia, Pérez-Sepulveda Alejandra, Muñiz Sabrina, Coronado-Arrázola Irenice, Acevedo Francisco, Soto Jorge A., Bueno Susan M., Sánchez Cesar, Kalergis Alexis M., Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients, Frontiers in Immunology, 11, 2020. Crossref

  45. Mattei Fabrizio, Andreone Sara, Marone Giancarlo, Gambardella Adriana Rosa, Loffredo Stefania, Varricchi Gilda, Schiavoni Giovanna, Eosinophils in the Tumor Microenvironment, in Tumor Microenvironment, 1273, 2020. Crossref

  46. Whiteside Theresa L., NK cells in the tumor microenvironment and thioredoxin activity, Journal of Clinical Investigation, 130, 10, 2020. Crossref

  47. Kaur Kawaljit, Ko Meng-Wei, Ohanian Nick, Cook Jessica, Jewett Anahid, Osteoclast-expanded super-charged NK-cells preferentially select and expand CD8+ T cells, Scientific Reports, 10, 1, 2020. Crossref

  48. Wieckowski Sébastien, Avenal Cécile, Orjalo Arturo V., Gygax Daniel, Cymer Florian, Toward a Better Understanding of Bioassays for the Development of Biopharmaceuticals by Exploring the Structure-Antibody-Dependent Cellular Cytotoxicity Relationship in Human Primary Cells, Frontiers in Immunology, 11, 2020. Crossref

  49. Rademacher Mary Jo, Cruz Anahi, Faber Mary, Oldham Robyn A. A., Wang Dandan, Medin Jeffrey A., Schloemer Nathan J., Sarcoma IL-12 overexpression facilitates NK cell immunomodulation, Scientific Reports, 11, 1, 2021. Crossref

  50. Ehlers Femke A. I., Mahaweni Niken M., Olieslagers Timo I., Bos Gerard M. J., Wieten Lotte, Activated Natural Killer Cells Withstand the Relatively Low Glucose Concentrations Found in the Bone Marrow of Multiple Myeloma Patients, Frontiers in Oncology, 11, 2021. Crossref

  51. Hsu Li-Jie, Liu Chao-Lin, Kuo Ming-Ling, Shen Chia-Ning, Shen Chia-Rui, An Alternative Cell Therapy for Cancers: Induced Pluripotent Stem Cell (iPSC)-Derived Natural Killer Cells, Biomedicines, 9, 10, 2021. Crossref

  52. Bozward Amber G., Warricker Frazer, Oo Ye H., Khakoo Salim I., Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade, Frontiers in Immunology, 12, 2021. Crossref

  53. Elahi Reza, Heidary Amir Hossein, Hadiloo Kaveh, Esmaeilzadeh Abdolreza, Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects, Stem Cell Reviews and Reports, 17, 6, 2021. Crossref

  54. Becicka Wyatt M., Bielecki Peter A., Lorkowski Morgan E., Moon Taylor J., Zhang Yahan, Atukorale Prabhani U., Covarrubias Gil, Karathanasis Efstathios, The effect of PEGylation on the efficacy and uptake of an immunostimulatory nanoparticle in the tumor immune microenvironment, Nanoscale Advances, 3, 17, 2021. Crossref

  55. Xiao Zheng, Nie Kechao, Han Tong, Cheng Lin, Zhang Zheyu, Peng Weijun, Shi Dazun, Zhong Jixin, Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients, Journal of Immunology Research, 2021, 2021. Crossref

  56. Costa da Silva Milene, Vieira Rocha Cátia, Bañobre-López Manuel, Gallo Juan, Stimulation and Suppression of the Innate Immune System through Nanotechnology, ACS Applied Nano Materials, 4, 3, 2021. Crossref

  57. Jhunjhunwala Suchit, Hammer Christian, Delamarre Lélia, Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion, Nature Reviews Cancer, 21, 5, 2021. Crossref

  58. Ding Hui, Buzzard Garrett W., Huang Sisi, Sehorn Michael G., Marcus R. Kenneth, Wei Yanzhang, Pizzo Salvatore V., MICA-G129R: A bifunctional fusion protein increases PRLR-positive breast cancer cell death in co-culture with natural killer cells, PLOS ONE, 16, 6, 2021. Crossref

  59. Phoon Yee Peng, Tannenbaum Charles, Diaz-Montero C. Marcela, Immunobiology of Melanoma, Clinics in Plastic Surgery, 48, 4, 2021. Crossref

  60. Kang Youngnam, Datta Pallab, Shanmughapriya Santhanam, Ozbolat Ibrahim T., 3D Bioprinting of Tumor Models for Cancer Research, ACS Applied Bio Materials, 3, 9, 2020. Crossref

  61. Karampatzakis Alexandros, Brož Petr, Rey Camille, Önfelt Björn, Cruz De Matos Gabriela Dos Santos, Rycroft Daniel, Ambrose Ashley, Davis Daniel M., Antibody Afucosylation Augments CD16-Mediated Serial Killing and IFNγ Secretion by Human Natural Killer Cells, Frontiers in Immunology, 12, 2021. Crossref

  62. Kirhan Idris, Taskiran Huseyin, Gönel Ataman, Effect of Conventional Chemotherapies on Natural Killer Cell Activity, Current Cancer Therapy Reviews, 17, 3, 2021. Crossref

  63. Rajendrakumar Santhosh Kalash, Uthaman Saji, Cho Chong-Su, Park In-Kyu, Nanoparticle-Based Phototriggered Cancer Immunotherapy and Its Domino Effect in the Tumor Microenvironment, Biomacromolecules, 19, 6, 2018. Crossref

  64. Kaur Kawaljit, Safaie Tahmineh, Ko Meng-Wei, Wang Yuhao, Jewett Anahid, ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor, Cancers, 13, 2, 2021. Crossref

  65. Manoochehri Mehdi, Hielscher Thomas, Borhani Nasim, Gerhäuser Clarissa, Fletcher Olivia, Swerdlow Anthony J., Ko Yon-Dschun, Brauch Hiltrud, Brüning Thomas, Hamann Ute, Epigenetic quantification of circulating immune cells in peripheral blood of triple-negative breast cancer patients, Clinical Epigenetics, 13, 1, 2021. Crossref

  66. Calinescu Anda-Alexandra, Kamran Neha, Baker Gregory, Mineharu Yohei, Lowenstein Pedro Ricardo, Castro Maria Graciela, Overview of current immunotherapeutic strategies for glioma, Immunotherapy, 7, 10, 2015. Crossref

  67. Sawasdee Nunghathai, Wattanapanitch Methichit, Thongsin Nontaphat, Phanthaphol Nattaporn, Chiawpanit Chutipa, Thuwajit Chanitra, Yenchitsomanus Pa-Thai, Panya Aussara, Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors, International Journal of Molecular Medicine, 49, 3, 2022. Crossref

  68. Li Joey H., O’Sullivan Timothy E., Back to the Future: Spatiotemporal Determinants of NK Cell Antitumor Function, Frontiers in Immunology, 12, 2022. Crossref

  69. Mylod Eimear, Lysaght Joanne, Conroy Melissa J., Natural killer cell therapy: A new frontier for obesity-associated cancer, Cancer Letters, 535, 2022. Crossref

  70. Neviani Paolo, Wise Petra M., Murtadha Mariam, Liu Cathy W., Wu Chun-Hua, Jong Ambrose Y., Seeger Robert C., Fabbri Muller, Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms, Cancer Research, 79, 6, 2019. Crossref

  71. Eckert Franziska, Jelas Ivan, Oehme Moritz, Huber Stephan M., Sonntag Katja, Welker Christian, Gillies Stephen D., Strittmatter Wolfgang, Zips Daniel, Handgretinger Rupert, Schilbach Karin, Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo, OncoImmunology, 6, 6, 2017. Crossref

  72. Woan Karrune V., Miller Jeffrey S., Harnessing Natural Killer Cell Antitumor Immunity: From the Bench to Bedside, Cancer Immunology Research, 7, 11, 2019. Crossref

  73. Li Ting, Copeland Christopher, Le Anne, Glutamine Metabolism in Cancer, in The Heterogeneity of Cancer Metabolism, 1311, 2021. Crossref

  74. Triki Hana, Charfi Slim, Bouzidi Lobna, Ben Kridis Wala, Daoud Jamel, Chaabane Kais, Sellami-Boudawara Tahia, Rebai Ahmed, Cherif Boutheina, CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration, Life Sciences, 231, 2019. Crossref

  75. Jurj Ancuta, Pasca Sergiu, Braicu Cornelia, Rusu Ioana, Korban Schuyler S., Berindan-Neagoe Ioana, Focus on organoids: cooperation and interconnection with extracellular vesicles – Is this the future of in vitro modeling?, Seminars in Cancer Biology, 2021. Crossref

  76. Zhuang Xiaoxuan, Long Eric O., CD28 Homolog Is a Strong Activator of Natural Killer Cells for Lysis of B7H7+ Tumor Cells, Cancer Immunology Research, 7, 6, 2019. Crossref

  77. Stephen Zachary R., Zhang Miqin, Recent Progress in the Synergistic Combination of Nanoparticle‐Mediated Hyperthermia and Immunotherapy for Treatment of Cancer, Advanced Healthcare Materials, 10, 2, 2021. Crossref

  78. Bhattacharya Sourav, Muhammad Naoshad, Steele Robert, Kornbluth Jacki, Ray Ratna B., Bitter Melon Enhances Natural Killer–Mediated Toxicity against Head and Neck Cancer Cells, Cancer Prevention Research, 10, 6, 2017. Crossref

  79. Nandagopal Saravanan, Li Caiyun G., Xu Yu, Sodji Quaovi H., Graves Edward E., Giaccia Amato J., C3aR Signaling Inhibits NK-cell Infiltration into the Tumor Microenvironment in Mouse Models, Cancer Immunology Research, 10, 2, 2022. Crossref

  80. Valenzuela Pedro L., Saco-Ledo Gonzalo, Santos-Lozano Alejandro, Morales Javier S., Castillo-García Adrián, Simpson Richard J., Lucia Alejandro, Fiuza-Luces Carmen, Exercise Training and Natural Killer Cells in Cancer Survivors: Current Evidence and Research Gaps Based on a Systematic Review and Meta-analysis, Sports Medicine - Open, 8, 1, 2022. Crossref

  81. Constantino João, Gomes Célia, Falcão Amílcar, Cruz Maria T., Neves Bruno M., Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives, Translational Research, 168, 2016. Crossref

  82. Kleinmanns Katrin, Gjerde Christiane Helgestad, Langer Anika, Fosse Vibeke, de Jalón Elvira García, Leitch Calum, Popa Mihaela, Gelebart Pascal, McCormack Emmet, Modeling the Tumor Microenvironment in Patient-Derived Xenografts: Challenges and Opportunities, in Biomarkers of the Tumor Microenvironment, 2022. Crossref

  83. Tamma Roberto, Annese Tiziana, Ribatti Domenico, The Role of Inflammatory Cells in Tumor Angiogenesis, in The Extracellular Matrix and the Tumor Microenvironment, 11, 2022. Crossref

  84. D'Aloia Maria Michela, Caratelli Sara, Palumbo Camilla, Battella Simone, Arriga Roberto, Lauro Davide, Palmieri Gabriella, Sconocchia Giuseppe, Alimandi Maurizio, T lymphocytes engineered to express a CD16-chimeric antigen receptor redirect T-cell immune responses against immunoglobulin G–opsonized target cells, Cytotherapy, 18, 2, 2016. Crossref

  85. Talaat Iman M., Elemam Noha M., Zaher Shroque, Saber-Ayad Maha, Checkpoint molecules on infiltrating immune cells in colorectal tumor microenvironment, Frontiers in Medicine, 9, 2022. Crossref

  86. Sabag Batel, Levy Moria, Kivelevitz Jessica, Dashevsky Nataly, Ben-Shmuel Aviad, Puthenveetil Abhishek, Awwad Fatima, Barda-Saad Mira, Actin Retrograde Flow Regulated by the Wiskott–Aldrich Syndrome Protein Drives the Natural Killer Cell Response, Cancers, 14, 15, 2022. Crossref

  87. Mealiea David, McCart J. Andrea, Cutting both ways: the innate immune response to oncolytic virotherapy, Cancer Gene Therapy, 29, 6, 2022. Crossref

  88. Yu Ding-Li, Lou Zhi-Ping, Ma Feng-Yun, Najafi Masoud, The interactions of paclitaxel with tumour microenvironment, International Immunopharmacology, 105, 2022. Crossref

  89. Balevičiūtė Austėja, Radzevičiūtė Eivina, Želvys Augustinas, Malyško-Ptašinskė Veronika, Novickij Jurij, Zinkevičienė Auksė, Kašėta Vytautas, Novickij Vitalij, Girkontaitė Irutė, High-Frequency Nanosecond Bleomycin Electrochemotherapy and its Effects on Changes in the Immune System and Survival, Cancers, 14, 24, 2022. Crossref

Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections Prices and Subscription Policies Begell House Contact Us Language English 中文 Русский Português German French Spain